The Glucosamine-study: The Effect of Glucosamine in Treatment of Chronic Low Back Pain
NCT00404079 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2011-04-29
Summary
Low back pain (LBP) is the most frequent cause of sick leave and disability pension, and degenerative and osteoarthritic (OA) changes is a significant cause of pain and disability. Some indications exist for symptomatic and possible cartilage-structurmodifying effect on knee- and hip-osteoarthritis with glucosamine sulphate (GS). The OA process in the lumbar spine is most likely to OA processes in knees and hips, hence GS could have comparable symptomatic and structural effect on lumbar OA.
Study hypothesis: No difference in treatment effect exists between oral intake of GS- or placebo-capsules for patients' with chronic low back pain measured with Roland Morris Disability Questionnaire.
Conditions
- Low Back Pain
Interventions
- DRUG
-
Glucosamine sulphate
Oral intake of 1500 mg glucosamine sulfate(from Pharma Nord) daily for 6 months
- DRUG
-
Oral intake of 3 placebo capsules (similiar looking to the glucosamine sulfate capsules)daily for 6 months
Sponsors & Collaborators
-
Stiftelsen Helse og Rehabilitering
collaborator OTHER -
Ullevaal University Hospital
lead OTHER
Principal Investigators
-
Oliver Grundnes, MD · Ullevaal University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2009-08-31
- Completion
- 2010-11-30
Countries
- Norway
Study Locations
More Related Trials
-
Trial of Oral Glutamine on Mitochondrial Function in CKD
NCT02838979 ·Status: COMPLETED ·Phase: PHASE2
-
Glucosamine and Chondroitin Effects
NCT01682694 ·Status: COMPLETED ·Phase: NA
-
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)
NCT02583672 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolic Analysis in Human Sulfur Amino Acid Deficiency
NCT00253760 ·Status: COMPLETED ·Phase: NA
-
N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)
NCT04706416 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy and Safety of an Amino Acid Supplement in Adults
NCT05599282 ·Status: COMPLETED ·Phase: PHASE2
-
Glutamate Supplementation in Young Men
NCT03425578 ·Status: COMPLETED ·Phase: NA
-
Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2
NCT04417218 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Chemical Interactions in Toxicity
NCT00253773 ·Status: COMPLETED ·Phase: NA
-
Dietary Effects of Sulfur Amino Acids
NCT00228618 ·Status: COMPLETED
-
Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study B
NCT00858273 ·Status: COMPLETED ·Phase: NA
-
Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation
NCT07050173 ·Status: RECRUITING ·Phase: PHASE1
-
Sublingual L-GSH Supplementation in Male Subjects With Smoking Habit and/or Hypertension
NCT02125045 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study)
NCT03063476 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Glutathione Supplementation on the Levels of Blood Glutathione
NCT01044277 ·Status: COMPLETED ·Phase: NA
-
The Effect of Glutamine on Systemic Inflammation During Human Experimental Endotoxemia
NCT00780520 ·Status: COMPLETED ·Phase: NA
-
Vitamin B6 Dependence of One-Carbon Metabolism
NCT00877812 ·Status: COMPLETED ·Phase: NA
-
A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder
NCT04886297 ·Status: COMPLETED ·Phase: PHASE3
-
Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
NCT04740580 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
DINAMITE Study Nutritional State and Effect Diet in Mitochondrial Disease
NCT02286856 ·Status: COMPLETED ·Phase: NA
-
Effect of N-acetylcysteine on Brain Glutamate
NCT02483130 ·Status: COMPLETED
-
Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents
NCT01111734 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of N-Acetyl Cysteine in Children With Autism
NCT00627705 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Acute Lysine Administration on α-aminoadipic Acid
NCT02756117 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione
NCT00228644 ·Status: COMPLETED